Quarterly report pursuant to Section 13 or 15(d)

Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details)

v3.23.1
Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Mar. 31, 2023
Mar. 31, 2022
Balances $ 1,827,106 $ 1,751,154 $ 1,701,011 $ 1,702,531 $ 1,646,955 $ 1,571,234 $ 1,701,011 $ 1,571,234
Balances (in shares)     156,644,212       156,644,212  
Net earnings 70,218 50,005 $ 89,734 60,144 72,059 68,981 $ 209,958 201,184
Other comprehensive income (loss) 1,574     4,328 4,808 (6,964) 1,616 $ 2,172
Other comprehensive loss 1,574 16,685 (16,762) 4,328        
Reclassification of cumulative translation adjustment for Eminence to non-operating income     119       $ 119  
Elimination of noncontrolling equity interest from sale of Eminence     613          
Share repurchases     (19,562) (60,838) (41,294)      
Common stock issued for exercise of options (8,860) 5,075 (2,005) 10,495 18,605 22,867    
Common stock issued for exercise of options (in shares)             1,271,338 2,220,412
Common stock issued for restricted stock awards (267) 2 (6,427) (159) 0 (9,765)    
Cash dividends (12,582) (12,561) (12,545) (12,577) (12,576) (12,493)    
Stock-based compensation expense 9,995 16,413 14,364 8,043 13,701 11,396    
Common stock issued to employee stock purchase plan 2,389   2,517 1,330 6 1,358    
Employee stock purchase plan expense 113 333 97 25 267 341    
Balances $ 1,889,686 1,827,106 1,751,154 1,713,322 1,702,531 1,646,955 $ 1,889,686 $ 1,713,322
Balances (in shares) 157,339,318           157,339,318  
Common Stock [Member]                
Balances $ 1,571 $ 1,569 $ 1,566 $ 1,573 $ 1,571 $ 1,558 $ 1,566 $ 1,558
Balances (in shares) 157,094,000 156,928,000 156,644,000 157,279,000 157,092,000 155,822,000 156,644,000 155,822,000
Share repurchases     $ (2) $ (5) $ (4)      
Share repurchases (in shares)     (222,000) (580,000) (357,000)      
Common stock issued for exercise of options $ 2 $ 1 $ 5 $ 3 $ 6 $ 12    
Common stock issued for exercise of options (in shares) 201,000 155,000 425,000 337,000 538,000 1,178,000    
Common stock issued for restricted stock awards $ 0 $ 1 $ 0 $ 0 $ 0 $ 1    
Common stock issued for restricted stock awards (in shares) 6,000 11,000 45,000 3,000 6,000 79,000    
Common stock issued to employee stock purchase plan $ 0   $ 0 $ 0   $ 0    
Common stock issued to employee stock purchase plan (in shares) 38,000   36,000 15,000   13,000    
Balances $ 1,573 $ 1,571 $ 1,569 $ 1,571 $ 1,573 $ 1,571 $ 1,573 $ 1,571
Balances (in shares) 157,339,000 157,094,000 156,928,000 157,054,000 157,279,000 157,092,000 157,339,000 157,054,000
Additional Paid-in Capital [Member]                
Balances $ 700,684 $ 678,863 $ 652,467 $ 615,242 $ 582,669 $ 533,239 $ 652,467 $ 533,239
Common stock issued for exercise of options 1,871 5,074 9,418 10,492 18,599 36,336    
Common stock issued for restricted stock awards 0 1 0 0 0 (1)    
Stock-based compensation expense 9,995 16,413 14,364 8,043 13,701 11,396    
Common stock issued to employee stock purchase plan 2,389   2,517 1,330 6 1,358    
Employee stock purchase plan expense 113 333 97 25 267 341    
Balances 715,052 700,684 678,863 635,132 615,242 582,669 715,052 635,132
Retained Earnings [Member]                
Balances 1,199,976 1,162,532 1,122,937 1,145,648 1,119,341 1,085,465 1,122,937 1,085,465
Net earnings 70,218 50,005 89,555 60,739 80,173 69,615    
Share repurchases     (19,560) (60,833) (41,290)      
Common stock issued for exercise of options (10,733)   (11,428)     (13,481)    
Common stock issued for restricted stock awards (267)   (6,427) (159)   (9,765)    
Cash dividends (12,582) (12,561) (12,545) (12,577) (12,576) (12,493)    
Balances 1,246,612 1,199,976 1,162,532 1,132,818 1,145,648 1,119,341 1,246,612 1,132,818
AOCI Attributable to Parent [Member]                
Balances (75,125) (91,810) (75,200) (59,474) (64,216) (57,291) (75,200) (57,291)
Other comprehensive income (loss)         4,742 (6,925)    
Other comprehensive loss 1,574 16,685 (16,762) 4,329        
Reclassification of cumulative translation adjustment for Eminence to non-operating income     152          
Balances $ (73,551) $ (75,125) (91,810) (55,145) (59,474) (64,216) (73,551) (55,145)
Noncontrolling Interest [Member]                
Balances     (759) (458) 7,590 8,263 $ (759) 8,263
Net earnings     179 (595) (8,114) (634)    
Other comprehensive income (loss)         66 (39)    
Other comprehensive loss       (1)        
Reclassification of cumulative translation adjustment for Eminence to non-operating income     (33)          
Elimination of noncontrolling equity interest from sale of Eminence     $ 613          
Balances       $ (1,054) $ (458) $ 7,590   $ (1,054)